Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 487-490

  Craig, LaTasha B ^a   Ke, Raymond W ^a   Kutteh, William H ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Fasting insulin; Insulin resistance; Miscarriage; Recurrent pregnancy loss

Indexed keywords

INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; PREGNANCY; PREVALENCE; REFERENCE VALUES;

EID: 0036732520     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03247-8     Document Type: Article

References (20)

1. Recurrent pregnancy loss
2. Plasminogen activator inhibitor activity; an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovarian syndrome
3. Continuing metformin throughout pregnancy in women with polycystic ovarian syndrome appears to safely reduce first-trimester spontaneous abortion; a pilot study
4. Polycystic ovaries and recurrent miscarriage-a reappraisal
5. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovarian syndrome
6. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies
7. Homeostasis model assessment; insulin resistance and β-cell function from fasting plasma glucose and insulin concentrates in man
8. Etiologic factors in women with a history of recurrent pregnancy loss
9. Frequency of factors associated with habitual abortion in 197 couples
10. Epidemiology of recurrent spontaneous abortion
11. An informative protocol for the investigation of recurrent miscarriage; preliminary experience of 500 consecutive cases
12. Glucose clamp techniques; a method of quantifying insulin secretion and resistance
13. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin activity; studies in subjects with various degrees of glucose tolerance and insulin sensitivity
14. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome
15. The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovarian syndrome
16. Insulin and glucose modulate glucose messenger ribonucleic acid expression and glucose uptake in trophoblasts isolated from first-trimester chorionic villi
17. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study
18. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology
19. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
20. Decreases in ovarian cytochrome P450C17-α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome